lobbying_activities: 1727101

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1727101	27a12f46-848e-4b41-9000-48c5b50f7ecc	Q3	AVANIR PHARMACEUTICALS	401103474	AVANIR PHARMACEUTICALS	2015	third_quarter	HCR	SGR Repeal, 21st Century Cures, Specialty Tier Price Cap Legislation, Patent Reform, Health Care Quality Measures	Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE		60000	0	0	2015-10-07T13:08:44.280000-04:00